160 related articles for article (PubMed ID: 33123802)
1. Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK.
Lloyd RS; Hingle MI; Bloomer JC; Charles SJ; Butler JM; Paul A; Zhu X; Miller B; D'Amico D; Donald A; Tal-Singer R; Ambery C
Pharm Res; 2020 Oct; 37(12):233. PubMed ID: 33123802
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterisation of a salt form of Danirixin with reduced pharmacokinetic variability in patient populations.
Bloomer JC; Ambery C; Miller BE; Connolly P; Garden H; Henley N; Hodnett N; Keel S; Kreindler JL; Lloyd RS; Matthews W; Yonchuk J; Lazaar AL
Eur J Pharm Biopharm; 2017 Aug; 117():224-231. PubMed ID: 28385615
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers.
Miller BE; Smart K; Mistry S; Ambery CL; Bloomer JC; Connolly P; Sanderson D; Shreeves T; Smith R; Lazaar AL
Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):173-81. PubMed ID: 24504700
[TBL] [Abstract][Full Text] [Related]
4. Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection.
Gajewska M; Blumenstein L; Kourentas A; Mueller-Zsigmondy M; Lorenzo S; Sinn A; Velinova M; Heimbach T
AAPS J; 2020 Oct; 22(6):134. PubMed ID: 33070288
[TBL] [Abstract][Full Text] [Related]
5. In-vitro-in-silico investigation of the negative food effect of zolpidem when administered as immediate-release tablets.
Paraiso RLM; Watanabe A; Andreas CJ; Turner D; Zane P; Dressman J
J Pharm Pharmacol; 2019 Nov; 71(11):1663-1676. PubMed ID: 31566757
[TBL] [Abstract][Full Text] [Related]
6. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
[TBL] [Abstract][Full Text] [Related]
7. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
Shono Y; Jantratid E; Dressman JB
Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Danirixin Hydrobromide Tablets in Japanese Healthy Elderly Participants.
Iida T; Matsuzawa Y; Ogura H; Nagakubo T; Wakamatsu A; Ambery C; Miller BE; Lazaar AL; Numachi Y
Clin Pharmacol Drug Dev; 2019 Nov; 8(8):1081-1087. PubMed ID: 31056840
[TBL] [Abstract][Full Text] [Related]
9. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study.
Shaik N; Hee B; Wei H; LaBadie RR
Cancer Chemother Pharmacol; 2019 Mar; 83(3):463-472. PubMed ID: 30536154
[TBL] [Abstract][Full Text] [Related]
11. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic investigation of the negative food effect of modified release zolpidem.
Andreas CJ; Pepin X; Markopoulos C; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Sci; 2017 May; 102():284-298. PubMed ID: 28286289
[TBL] [Abstract][Full Text] [Related]
13. Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An
Piscitelli J; Hens B; Tomaszewska I; Wollenberg L; Litwiler K; McAllister M; Reddy M
Mol Pharm; 2023 May; 20(5):2589-2599. PubMed ID: 37037186
[TBL] [Abstract][Full Text] [Related]
14. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.
Jones HM; Parrott N; Ohlenbusch G; Lavé T
Clin Pharmacokinet; 2006; 45(12):1213-26. PubMed ID: 17112297
[TBL] [Abstract][Full Text] [Related]
15. Use of Physiologically Based Pharmacokinetic Modeling for Predicting Drug-Food Interactions: Recommendations for Improving Predictive Performance of Low Confidence Food Effect Models.
Wagner C; Kesisoglou F; Pepin XJH; Parrott N; Emami Riedmaier A
AAPS J; 2021 Jun; 23(4):85. PubMed ID: 34142242
[TBL] [Abstract][Full Text] [Related]
16. On the usefulness of compendial setups and tiny-TIM system in evaluating the in vivo performance of oral drug products with various release profiles in the fasted state: Case example sodium salt of A6197.
Schilderink R; Protopappa M; Fleth-James J; Vertzoni M; Schaefer K; Havenaar R; Kulla I; Metzger M; Reppas C
Eur J Pharm Biopharm; 2020 Apr; 149():154-162. PubMed ID: 32057905
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of food effect on the oral absorption of clarithromycin from immediate release tablet using physiological modelling.
Radwan A; Jayyousi R; Shraim N; Zaid AN
Biopharm Drug Dispos; 2019 Apr; 40(3-4):121-134. PubMed ID: 30891805
[TBL] [Abstract][Full Text] [Related]
18. Biopharmaceutic
Arora S; Pansari A; Kilford P; Jamei M; Gardner I; Turner DB
Mol Pharm; 2020 Jul; 17(7):2329-2344. PubMed ID: 32427480
[TBL] [Abstract][Full Text] [Related]
19. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
[TBL] [Abstract][Full Text] [Related]
20. A physiologically-based drug absorption modeling for orally disintegrating tablets.
Kambayashi A; Kiyota T
Eur J Pharm Biopharm; 2020 Jul; 152():1-9. PubMed ID: 32371153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
